DNA Bridges, Inc. is a leading corporate development firm that leverages seasoned scientific and business talent in the life sciences, device and pharmaceutical industries to bridge science and products.

FROM DISCOVERY TO LAUNCH our team has developed and supported the commercialization of products with combined sales over $10 billion USD. These include Herceptin, Xolair, Activase, Raptiva and Kogenate.